Nano-Based Drug Delivery Systems of Potent MmpL3 Inhibitors for Tuberculosis Treatment

Nano-Based Drug Delivery Systems of Potent MmpL3 Inhibitors for Tuberculosis Treatment

Tuberculosis remains one of the world’s deadliest infectious diseases, accounting for nearly 1.3 million deaths every year. Tuberculosis treatment is challenging because of the toxicity, decreased bioavailability at the target site of the conventional drugs and, most importantly, low adherence of pa...

Full description

Bibliographic Details
Main Authors: Patrizia Nadia Hanieh, Sara Consalvi, Jacopo Forte, Gianluigi Cabiddu, Alessandro De Logu, Giovanna Poce, Federica Rinaldi, Mariangela Biava, Maria Carafa, Carlotta Marianecci
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Pharmaceutics
Subjects:
nanocarriers
niosomes
nanoemulsions
tuberculosis
Online Access:https://www.mdpi.com/1999-4923/14/3/610

Internet

https://www.mdpi.com/1999-4923/14/3/610

Similar Items